Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic
Available funding totaling EUR 20 million dedicated to developing novel solid tumor treatments addressing a high unmet medical need Springboard Health Angels, Pluton Asset Holding AG, Sintra Limited, and Technologiegrunderfonds Sachsen joined as new investors Existing investors i&i Biotech Fund I SCSp, HIL-INVENT and Brandenburg Kapital also participated in the round Schoenefeld/Berlin, Germany, November 17, […]